Israel Englander Organogenesis Holdings Inc. Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Millennium Management LLC holds 83,228 shares of ORGO stock, worth $377,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,228

Previous 138,980 40.12%

Holding current value

$377,022

Previous $508,000 25.79%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.78 - $5.03 $210,742 - $280,432	-55,752 Reduced 40.12%	83,228 $377,000
Q2 2025 Aug 14, 2025	SELL	$2.66 - $5.34 $58,708 - $117,859	-22,071 Reduced 13.7%	138,980 $508,000
Q1 2025 May 15, 2025	SELL	$2.89 - $6.21 $136,896 - $294,161	-47,369 Reduced 22.73%	161,051 $695,000
Q4 2024 Feb 14, 2025	BUY	$2.77 - $4.43 $15,969 - $25,538	5,765 Added 2.84%	208,420 $666,000
Q3 2024 Nov 14, 2024	BUY	$2.42 - $3.24 $166,525 - $222,950	68,812 Added 51.41%	202,655 $579,000

Q2 2024 Aug 14, 2024	SELL	$2.28 - $3.03 $175,361 - $233,046	-76,913 Reduced 36.49%	133,843 $374,000
Q1 2024 May 15, 2024	SELL	$2.61 - $4.49 $1.92 Million - $3.3 Million	-735,458 Reduced 77.73%	210,756 $598,000
Q4 2023 Feb 14, 2024	SELL	$1.97 - $4.21 $2.43 Million - $5.19 Million	-1,232,872 Reduced 56.58%	946,214 $3.87 Million
Q2 2023 Aug 14, 2023	BUY	$1.9 - $4.3 $1.13 Million - $2.56 Million	594,812 Added 37.54%	2,179,086 $7.23 Million
Q1 2023 May 15, 2023	SELL	$1.89 - $2.93 $270,247 - $418,954	-142,988 Reduced 8.28%	1,584,274 $3.38 Million
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $574,697 - $794,844	231,733 Added 15.5%	1,727,262 $4.65 Million
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $2.92 Million - $5.98 Million	929,727 Added 164.32%	1,495,529 $4.85 Million
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $4.06 Million - $6.98 Million	-856,176 Reduced 60.21%	565,802 $2.76 Million
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $1.47 Million - $2.18 Million	227,852 Added 19.08%	1,421,978 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $6.3 Million - $9.43 Million	698,263 Added 140.82%	1,194,126 $11 Million
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $6.78 Million - $8.5 Million	-494,584 Reduced 49.94%	495,863 $7.06 Million
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $11.3 Million - $17.6 Million	758,062 Added 326.21%	990,447 $16.5 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $992,364 - $2.85 Million	135,384 Added 139.57%	232,385 $4.23 Million
Q4 2020 Feb 16, 2021	BUY	$3.63 - $7.53 $352,113 - $730,417	97,001 New	97,001 $730,000
Q2 2020 Aug 14, 2020	SELL	$2.86 - $4.61 $225,814 - $363,987	-78,956 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.92 - $5.31 $241,863 - $439,827	-82,830 Reduced 51.2%	78,956 $255,000
Q4 2019 Feb 14, 2020	BUY	$4.7 - $8.11 $760,394 - $1.31 Million	161,786 New	161,786 $778,000
Q3 2019 Nov 14, 2019	SELL	$3.57 - $8.09 $60,254 - $136,543	-16,878 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.58 - $8.69 $278,577 - $367,908	-42,337 Reduced 71.5%	16,878 $128,000
Q1 2019 May 14, 2019	BUY	$7.05 - $150.0 $417,465 - $8.88 Million	59,215 New	59,215 $444,000

Others Institutions Holding ORGO

# of Institutions

127

Shares Held

69.1M

Call Options Held

39.7K

Put Options Held

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $593M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account